Albert Kheradpour

Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations

Erdem Göker, Mark Waltham, Albert Kheradpour et al. · Blood · 1995 · 146 citations · Full text

Medicine, Genetics, Molecular Genetics +10

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia et al. · Journal of Clinical Oncology · 2024 · 96 citations · Full text

Medicine, Oncology, Pharmacology +11

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

David A. Jacobsohn, Michael R. Loken, Mingwei Fei et al. · Biology of Blood and Marrow Transplantation · 2018 · 42 citations · Full text

Medicine, Hematology, Pediatrics +15

Response to Lenvatinib in Children with Papillary Thyroid Carcinoma

Priya Mahajan, Jonathan Dawrant, Albert Kheradpour et al. · Thyroid · 2018 · 33 citations

Medicine, Oncology, Pharmacotherapy +11

Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.

Erdem Göker, Albert Kheradpour, Mark Waltham et al. · PubMed · 1995 · 30 citations

Medicine, Hematology, Oncology +13